Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9302)
All Articles published online
|
Publishing Process of This Article
|
Dec 28, 2015 (publication date) through Nov 30, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Lin WC, Wong JM, Tung CC, Lin CP, Chou JW, Wang HY, Shieh MJ, Chang CH, Liu HH, Wei SC, Taiwan Society of Inflammatory Bowel Disease Multicenter Study. Fecal calprotectin correlated with endoscopic remission for Asian inflammatory bowel disease patients. World J Gastroenterol 2015; 21(48): 13566-13573 [PMID: 26730169 DOI: 10.3748/wjg.v21.i48.13566] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i48/13566.htm |
| Number | Citing Articles |
| 1 |
Anna Luisa Bathe, Eirini Mavropoulou, Nicolae-Catalin Mechie, Golo Petzold, Volker Ellenrieder, Steffen Kunsch, Ahmad Amanzada, Bruno Bonaz. Impact of faecal calprotectin measurement on clinical decision-making in patients with Crohn’s disease and ulcerative colitis. PLOS ONE 2019; 14(10): e0223893 doi: 10.1371/journal.pone.0223893
|
| 2 |
Shiro Nakamura, Hirotsugu Imaeda, Hiroki Nishikawa, Masaki Iimuro, Minoru Matsuura, Hideo Oka, Junsuke Oku, Takako Miyazaki, Hirohito Honda, Kenji Watanabe, Hiroshi Nakase, Akira Andoh. Usefulness of fecal calprotectin by monoclonal antibody testing in adult Japanese with inflammatory bowel diseases: a prospective multicenter study. Intestinal Research 2018; 16(4): 554 doi: 10.5217/ir.2018.00027
|
| 3 |
Shu-Chen Wei, Ting-An Chang, Te-Hsin Chao, Jinn-Shiun Chen, Jen-Wei Chou, Yenn-Hwei Chou, Chiao-Hsiung Chuang, Wen-Hung Hsu, Tien-Yu Huang, Tzu-Chi Hsu, Chun-Chi Lin, Hung-Hsin Lin, Jen-Kou Lin, Wei-Chen Lin, Yen-Hsuan Ni, Ming-Jium Shieh, I-Lun Shih, Chia-Tung Shun, Yuk-Ming Tsang, Cheng-Yi Wang, Horng-Yuan Wang, Meng-Tzu Weng, Deng-Chyang Wu, Wen-Chieh Wu, Hsu-Heng Yen, Jau-Min Wong. Management of Crohn's disease in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease. Intestinal Research 2017; 15(3): 285 doi: 10.5217/ir.2017.15.3.285
|
| 4 |
Mariusz A. Bromke, Katarzyna Neubauer, Radosław Kempiński, Małgorzata Krzystek-Korpacka. Faecal Calprotectin in Assessment of Mucosal Healing in Adults with Inflammatory Bowel Disease: A Meta-Analysis. Journal of Clinical Medicine 2021; 10(10): 2203 doi: 10.3390/jcm10102203
|
| 5 |
Ebby George Simon, Richard Wardle, Aye Aye Thi, Jeanette Eldridge, Sunil Samuel, Gordon William Moran. Does fecal calprotectin equally and accurately measure disease activity in small bowel and large bowel Crohn’s disease?: a systematic review . Intestinal Research 2019; 17(2): 160 doi: 10.5217/ir.2018.00114
|
| 6 |
Gang Peng, Huanyu Guan, Xiaoming Wang, Yue Shi. Simultaneous determination of 14 active constituents of Shengjiang Xiexin decoction using ultrafast liquid chromatography coupled with electrospray ionization tandem mass spectrometry. Acta Pharmaceutica Sinica B 2017; 7(2): 193 doi: 10.1016/j.apsb.2016.11.006
|
| 7 |
Shu-Chen Wei, Ting-An Chang, Te-Hsin Chao, Jinn-Shiun Chen, Jen-Wei Chou, Yenn-Hwei Chou, Chiao-Hsiung Chuang, Wen-Hung Hsu, Tien-Yu Huang, Tzu-Chi Hsu, Chun-Chi Lin, Hung-Hsin Lin, Jen-Kou Lin, Wei-Chen Lin, Yen-Hsuan Ni, Ming-Jium Shieh, I-Lun Shih, Chia-Tung Shun, Yuk-Ming Tsang, Cheng-Yi Wang, Horng-Yuan Wang, Meng-Tzu Weng, Deng-Chyang Wu, Wen-Chieh Wu, Hsu-Heng Yen, Jau-Min Wong. Management of ulcerative colitis in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease. Intestinal Research 2017; 15(3): 266 doi: 10.5217/ir.2017.15.3.266
|
| 8 |
Dan Turner, Frank M. Ruemmele, Esther Orlanski‐Meyer, Anne M. Griffiths, Javier Martin de Carpi, Jiri Bronsky, Gabor Veres, Marina Aloi, Caterina Strisciuglio, Christian P. Braegger, Amit Assa, Claudio Romano, Séamus Hussey, Michael Stanton, Mikko Pakarinen, Lissy de Ridder, Konstantinos Katsanos, Nick Croft, Victor Navas‐López, David C. Wilson, Sally Lawrence, Richard K. Russell. Management of Paediatric Ulcerative Colitis, Part 1. Journal of Pediatric Gastroenterology and Nutrition 2018; 67(2): 257 doi: 10.1097/MPG.0000000000002035
|
| 9 |
Natsuki Ishida, Tatsuhiro Ito, Kenichi Takahashi, Yusuke Asai, Takahiro Miyazu, Tomohiro Higuchi, Satoshi Tamura, Shinya Tani, Mihoko Yamade, Moriya Iwaizumi, Yasushi Hamaya, Satoshi Osawa, Ken Sugimoto. Comparison of fecal calprotectin levels and endoscopic scores for predicting relapse in patients with ulcerative colitis in remission. World Journal of Gastroenterology 2023; 29(47): 6111-6121 doi: 10.3748/wjg.v29.i47.6111
Abstract(373) |
Core Tip(405) |
Full Article(HTML)(1865)
|
Full Article with Cover (PDF)-5111K(97)
|
Full Article (Word)-552K(29)
|
Audio-1152K(8)
|
Peer-Review Report-224K(37)
|
Answering Reviewers-34K(38)
|
Full Article (PDF)-1311K(144)
|
Full Article (XML)-117K(33)
|
Times Cited (2)
|
Total Visits (5184)
|
Open
|
| 10 |
Francisco Guilherme Cancela e Penna, Rodrigo Macedo Rosa, Pedro Ferrari Sales da Cunha, Stella Cristina Silva de Souza, Maria de Lourdes de Abreu Ferrari. Faecal calprotectin is the biomarker that best distinguishes remission from different degrees of endoscopic activity in Crohn’s disease. BMC Gastroenterology 2020; 20(1) doi: 10.1186/s12876-020-1183-x
|
| 11 |
Francisco Guilherme Cancela Penna, Rodrigo Macedo Rosa, Fernando H. Pereira, Pedro Ferrari Sales Cunha, Stella Cristina S. Sousa, Teresa Cristina A. Ferrari, Carlos Cara, Maria de Lourdes A. Ferrari. Combined evaluation of fecal calprotectin and C-reactive protein as a therapeutic target in the management of patients with Crohn's disease. Gastroenterología y Hepatología 2021; 44(2): 87 doi: 10.1016/j.gastrohep.2020.04.015
|
| 12 |
Małgorzata Krzystek-Korpacka, Radosław Kempiński, Mariusz Bromke, Katarzyna Neubauer. Biochemical Biomarkers of Mucosal Healing for Inflammatory Bowel Disease in Adults. Diagnostics 2020; 10(6): 367 doi: 10.3390/diagnostics10060367
|
| 13 |
Chunhui Bao, Luyi Wu, Di Wang, Liming Chen, Xiaoming Jin, Yin Shi, Guona Li, Jingzhi Zhang, Xiaoqing Zeng, Jianhua Chen, Huirong Liu, Huangan Wu. Acupuncture improves the symptoms, intestinal microbiota, and inflammation of patients with mild to moderate Crohn's disease: A randomized controlled trial. eClinicalMedicine 2022; 45: 101300 doi: 10.1016/j.eclinm.2022.101300
|
| 14 |
James Guoxian Huang, Pornthep Tanpowpong. Paediatric gastrointestinal endoscopy in the Asian-Pacific region: Recent advances in diagnostic and therapeutic techniques. World Journal of Gastroenterology 2023; 29(18): 2717-2732 doi: 10.3748/wjg.v29.i18.2717
|
| 15 |
Fumihiko Iwamoto, Katsuyoshi Matsuoka, Maiko Motobayashi, Kento Takenaka, Toru Kuno, Keisuke Tanaka, Yuya Tsukui, Shoji Kobayashi, Takashi Yoshida, Toshimitsu Fujii, Eiko Saito, Tatsuya Yamaguchi, Masakazu Nagahori, Tadashi Sato, Kazuo Ohtsuka, Nobuyuki Enomoto, Mamoru Watanabe. Prediction of disease activity of Crohn's disease through fecal calprotectin evaluated by balloon‐assisted endoscopy. Journal of Gastroenterology and Hepatology 2018; 33(12): 1984 doi: 10.1111/jgh.14310
|
| 16 |
Monica State, Lucian Negreanu, Theodor Voiosu, Andrei Voiosu, Paul Balanescu, Radu Bogdan Mateescu. Surrogate markers of mucosal healing in inflammatory bowel disease: A systematic review. World Journal of Gastroenterology 2021; 27(16): 1828-1840 doi: 10.3748/wjg.v27.i16.1828
|
| 17 |
Seung Yong Shin, Soo Jung Park, Young Kim, Jong Pil Im, Hyo Jong Kim, Kang-Moon Lee, Ji Won Kim, Sung-Ae Jung, Jun Lee, Sang-Bum Kang, Sung Jae Shin, Eun Sun Kim, You Sun Kim, Tae Oh Kim, Hyun-Soo Kim, Dong Il Park, Hyung Kil Kim, Eun Soo Kim, Young-Ho Kim, Do Hyun Kim, Dennis Teng, Jong-Hwa Kim, Wonyong Kim, Chang Hwan Choi. Clinical outcomes and predictors of response for adalimumab in patients with moderately to severely active ulcerative colitis: a KASID prospective multicenter cohort study. Intestinal Research 2022; 20(3): 350 doi: 10.5217/ir.2021.00049
|
| 18 |
Jia-Feng Wu, Hsu-Heng Yen, Horng-Yuan Wang, Ting-An Chang, Chung-Hsin Chang, Chen-Wang Chang, Te-Hsin Chao, Jen-Wei Chou, Yenn-Hwei Chou, Chiao-Hsiung Chuang, Wen-Hung Hsu, Tzu-Chi Hsu, Tien-Yu Huang, Tsung-I Hung, Puo-Hsien Le, Chun-Che Lin, Chun-Chi Lin, Ching-Pin Lin, Jen-Kou Lin, Wei-Chen Lin, Yen-Hsuan Ni, Ming-Jium Shieh, I-Lun Shih, Chia-Tung Shun, Tzung-Jiun Tsai, Cheng-Yi Wang, Meng-Tzu Weng, Jau-Min Wong, Deng-Chyang Wu, Shu-Chen Wei. Management of Crohn’s disease in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease updated in 2023. Intestinal Research 2024; 22(3): 250 doi: 10.5217/ir.2024.00060
|
| 19 |
Hsu-Heng Yen, Mei-Wen Chen, Yu-Yao Chang, Hsuan-Yuan Huang, Tsui-Chun Hsu, Yang-Yuan Chen. Predictive values of stool-based tests for mucosal healing among Taiwanese patients with ulcerative colitis: a retrospective cohort analysis. PeerJ 2020; 8: e9537 doi: 10.7717/peerj.9537
|
| 20 |
Ting Zhang, Hang Zhong, Lu Lin, Zhiyan Zhang, Kewen Xue, Feixiang He, Yingshu Luo, Panpan Wang, Zhi Zhao, Li Cong, Pengfei Pang, Xiaofeng Li, Hong Shan, Zhixiang Yan. Core microbiome-associated proteins associated with ulcerative colitis interact with cytokines for synergistic or antagonistic effects on gut bacteria. The ISME Journal 2024; 18(1) doi: 10.1093/ismejo/wrae146
|
| 21 |
Ashish Kumar Jha, Madhur Chaudhary, Vishwa Mohan Dayal, Amarendra Kumar, Sanjeev Kumar Jha, Praveen Jha, Shubham Purkayastha, Ravish Ranjan. Optimal cut‐off value of fecal calprotectin for the evaluation of ulcerative colitis: An unsolved issue?. JGH Open 2018; 2(5): 207 doi: 10.1002/jgh3.12074
|
| 22 |
Shu-Chen Wei, Chien-Chih Tung, Meng-Tzu Weng, Jau-Min Wong. Experience of patients with inflammatory bowel disease in using a home fecal calprotectin test as an objective reported outcome for self-monitoring. Intestinal Research 2018; 16(4): 546 doi: 10.5217/ir.2018.00052
|
| 23 |
Yun-Gi Lee, Jisu Hong, Pureun-Haneul Lee, Junehyuk Lee, Sung-Woo Park, DoJin Kim, An-Soo Jang. Serum Calprotectin Is a Potential Marker in Patients with Asthma. Journal of Korean Medical Science 2020; 35(43) doi: 10.3346/jkms.2020.35.e362
|
| 24 |
Sun-Ho Lee, Min-Ju Kim, Kiju Chang, Eun Mi Song, Sung Wook Hwang, Sang Hyoung Park, Dong-Hoon Yang, Kyung-Jo Kim, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang, Byong Duk Ye. Fecal calprotectin predicts complete mucosal healing and better correlates with the ulcerative colitis endoscopic index of severity than with the Mayo endoscopic subscore in patients with ulcerative colitis. BMC Gastroenterology 2017; 17(1) doi: 10.1186/s12876-017-0669-7
|
| 25 |
Shu Chen Wei. Could fecal calprotectin enter mainstream use for diagnosing and monitoring inflammatory bowel disease?. Intestinal Research 2016; 14(4): 293 doi: 10.5217/ir.2016.14.4.293
|
| 26 |
Maki Jitsumura, Rory Frederick Kokelaar, Dean Anthony Harris. Remission endpoints in ulcerative colitis: A systematic review. World Journal of Meta-Analysis 2017; 5(4): 85-102 doi: 10.13105/wjma.v5.i4.85
|
| 27 |
Jun Kato, Takeichi Yoshida, Sakiko Hiraoka. Prediction of treatment outcome and relapse in inflammatory bowel disease. Expert Review of Clinical Immunology 2019; 15(6): 667 doi: 10.1080/1744666X.2019.1593140
|
| 28 |
Feng-Pai Tsai, Meng-Tzu Weng, Chin-Hao Chang, Ming-Huan Zeng, Shu-Chen Wei. A simplified fecal leukocyte esterase strip test results as a low cost, widely available, alternative bowel inflammation biomarker. Journal of the Formosan Medical Association 2024; 123(10): 1099 doi: 10.1016/j.jfma.2024.01.025
|
| 29 |
A. A. Sheptulin, S. S. Kardasheva, A. A. Kurbatova. Diagnostic Possibilities of Determining the Level of Faecal Calprotectin in Clinical Practice. Russian Journal of Gastroenterology, Hepatology, Coloproctology 2022; 32(6): 53 doi: 10.22416/1382-4376-2022-32-6-53-59
|
| 30 |
Alexandre Jentzer, Anne-Emmanuelle Depincé-Berger, Christian Genin, Xavier Roblin, Stéphane Paul. Nouveaux marqueurs diagnostiques et pronostiques des maladies chroniques inflammatoires intestinales. Revue Francophone des Laboratoires 2016; 2016(484): 49 doi: 10.1016/S1773-035X(16)30223-4
|
| 31 |
Francisco Guilherme Cancela Penna, Rodrigo Macedo Rosa, Fernando H. Pereira, Pedro Ferrari Sales Cunha, Stella Cristina S. Sousa, Teresa Cristina A. Ferrari, Carlos Cara, Maria de Lourdes A. Ferrari. Combined evaluation of fecal calprotectin and C-reactive protein as a therapeutic target in the management of patients with Crohn's disease. Gastroenterología y Hepatología (English Edition) 2021; 44(2): 87 doi: 10.1016/j.gastre.2020.04.010
|
| 32 |
Wei‐Chen Lin, Chen‐Wang Chang, Tsang‐En Wang, Horng‐Yuan Wang, Shou‐Chuan Shih, Cheng‐Hsin Chu, Tzu‐Chi Hsu. Endoscopic features and treatment response have better prediction rate than clinical symptoms/signs in distinguishing Crohn's disease and intestinal tuberculosis. Advances in Digestive Medicine 2017; 4(4): 121 doi: 10.1002/aid2.12121
|
| 33 |
Yoshiharu Yamaguchi, Hisatsugu Noda, Noriko Okaniwa, Kazunori Adachi, Tetsuya Shinmura, Shoko Nakagawa, Masahide Ebi, Naotaka Ogasawara, Yasushi Funaki, Lisheng Zhuo, Koji Kimata, Makoto Sasaki, Kunio Kasugai. Serum-Derived Hyaluronan-Associated Protein Is a Novel Biomarker for Inflammatory Bowel Diseases. Digestion 2017; 95(2): 146 doi: 10.1159/000456071
|
| 34 |
Lei Ye, Bi Qin Chen, Shao Dong Wang, Hui Shi, Zhao Yang, Fang Yu Wang. Fecal calprotectin is a strong predictive marker of relapse in Chinese patients with Crohn’s disease: a two-year prospective study. Scandinavian Journal of Gastroenterology 2017; 52(10): 1113 doi: 10.1080/00365521.2017.1346704
|
| 35 |
Hau-Jyun Su, Yu-Tse Chiu, Chuan-Tai Chiu, Yen-Chun Lin, Chen-Yu Wang, Jui-Ying Hsieh, Shu-Chen Wei. Inflammatory bowel disease and its treatment in 2018: Global and Taiwanese status updates. Journal of the Formosan Medical Association 2019; 118(7): 1083 doi: 10.1016/j.jfma.2018.07.005
|
| 36 |
Alissa Walsh, Andrey Kormilitzin, Christopher Hinds, Vanashree Sexton, Oliver Brain, Satish Keshav, Holm Uhlig, John Geddes, Guy Goodwin, Michele Peters, Gary Collins, Simon Travis. Defining Faecal Calprotectin Thresholds as a Surrogate for Endoscopic and Histological Disease Activity in Ulcerative Colitis—a Prospective Analysis. Journal of Crohn's and Colitis 2019; 13(4): 424 doi: 10.1093/ecco-jcc/jjy184
|
| 37 |
Taku Kobayashi, Britta Siegmund, Catherine Le Berre, Shu Chen Wei, Marc Ferrante, Bo Shen, Charles N. Bernstein, Silvio Danese, Laurent Peyrin-Biroulet, Toshifumi Hibi. Ulcerative colitis. Nature Reviews Disease Primers 2020; 6(1) doi: 10.1038/s41572-020-0205-x
|